Claims for Patent: 8,911,768
✉ Email this page to a colleague
Summary for Patent: 8,911,768
Title: | Methods for treating retinopathy with extended therapeutic effect |
Abstract: | Methods for treating and preventing retinopathic conditions by administering an anti-VEGF compound to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy. |
Inventor(s): | Whitcup; Scott M. (Laguna Hills, CA), Weber; David A. (Danville, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 14/306,363 |
Patent Claims: | 1. An ocular implant for treating macular degeneration comprising an active agent and a carrier associated with the active agent, wherein the carrier comprises a 30/10 w/w
mixture of hydrophilic end PLGA and hydrophobic end PLGA, wherein the active agent is ranibizumab and wherein the implant is formed by an extrusion method.
2. The ocular implant of claim 1, wherein the total weight of the ocular implant is between about 100 .mu.g and about 2 mg. 3. The ocular implant of claim 1, wherein the ocular implant contains about 100-300 .mu.g of ranibizumab. |
Details for Patent 8,911,768
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | 06/30/2006 | ⤷ Try a Trial | 2024-04-30 |
Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | 08/10/2012 | ⤷ Try a Trial | 2024-04-30 |
Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | 10/13/2016 | ⤷ Try a Trial | 2024-04-30 |
Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | 03/20/2018 | ⤷ Try a Trial | 2024-04-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.